Health-related quality of life burden in scleroderma patients treated with two different intravenous iloprost regimens

• Egile Nagusiak: T. Schioppo (Egilea), L. Scalone (Egilea), P. Cozzolino (Egilea), L. Mantovani (Egilea), G. Cesana (Egilea), O. De Lucia (Egilea), A. Murgo (Egilea), F. Ingegnoli (Egilea)
• Formatua: Liburua
• Argitaratua: PAGEPress Publications, 2019-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Systemic sclerosis (SSc)-related Raynaud's phenomenon (RP) and digital ulcers (DU) can impair health-related quality of life (HRQoL). The aim of our study was to estimate HRQoL in SSc patients treated with two different intravenous (IV) iloprost (ILO) regimens and in patients not treated with I...